||Reference : The combined effect of SR4233 (Tirapazamine®) and FMdC on radiation sensitivity in vitro...
|Scientific congresses and symposiums : Paper published in a journal|
|Human health sciences : Oncology|
|The combined effect of SR4233 (Tirapazamine®) and FMdC on radiation sensitivity in vitro and in vivo: is this effect linked to inhibition of angiogenesis?|
|COUCKE, Philippe [CHUV Lausanne > > Radiothérapie > >]|
|Cottin, E. [ > > ]|
|File(s) associated to this reference|
All documents in ORBi are protected by a user license.